Toby Maher, MD, PhD, professor of clinical medicine, Keck Medicine of USC, discusses the impact of changes in lung function in patients with idiopathic pulmonary fibrosis (IPF). How does the rate of ...
A pair of studies presented at the European Respiratory Society Congress 2024 emphasized the importance of close monitoring and proactive treatment approaches for patients with idiopathic (IPF) and ...
MedPage Today on MSN
Inhaled vasodilator slows lung function decline in idiopathic pulmonary fibrosis
Clinical worsening also occurred less frequently with treprostinil ...
Dose-ranging trial evaluated deupirfenidone 550 mg three times a day (TID) (approximately equivalent exposure to pirfenidone 801 mg TID 1) and deupirfenidone 825 mg TID and successfully demonstrated ...
SAN DIEGO — Patients with idiopathic pulmonary fibrosis (IPF) had significant improvements in lung function and reversal of lung fibrosis measures after 12 weeks of therapy with an investigational ...
Please provide your email address to receive an email when new articles are posted on . Few patients with IPF reported gastrointestinal side effects during buloxibutid treatment. Planned future ...
– Systemic sclerosis (SSc) is a rare disease that impacts up to 75,000 people in the United States – – Approximately 80% of SSc patients may be affected by interstitial lung disease (ILD), a ...
What are pulmonary function tests? Pulmonary function tests (PFTs) are tests of lung function. They are intended to evaluate and monitor chronic obstructive pulmonary disease (COPD). COPD is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results